Applied Biosciences (Applied Biosciences) Gross-Profit-to-Asset % : 13.68% (As of Dec. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Applied Biosciences Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Applied Biosciences's annualized Gross Profit for the quarter that ended in Dec. 2019 was $0.47 Mil. Applied Biosciences's average Total Assets over the quarter that ended in Dec. 2019 was $3.45 Mil. Therefore, Applied Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2019 was 13.68%.

Applied Biosciences Gross-Profit-to-Asset % Historical Data

The historical data trend for Applied Biosciences's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Biosciences Gross-Profit-to-Asset % Chart

Applied Biosciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Gross-Profit-to-Asset %

2.33

3.53

Applied Biosciences Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															9.66	22.42	12.49	16.67	13.68

Competitive Comparison of Applied Biosciences's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Applied Biosciences's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Applied Biosciences's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Applied Biosciences's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Applied Biosciences's Gross-Profit-to-Asset % falls into.

Applied Biosciences Gross-Profit-to-Asset % Calculation

Applied Biosciences's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2018 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2018 )	/	( (Total Assets (A: Mar. 2017 )	+	Total Assets (A: Mar. 2018 ))	/ count )
	=	0.042	/	( (1.676	+	0.705)	/ 2 )
	=	0.042	/	1.1905
	=	3.53 %

Applied Biosciences's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2019 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2019 )	/	( (Total Assets (Q: Sep. 2019 )	+	Total Assets (Q: Dec. 2019 ))	/ count )
	=	0.472	/	( (3.484	+	3.418)	/ 2 )
	=	0.472	/	3.451
	=	13.68 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2019) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Applied Biosciences Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Applied Biosciences's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Applied Biosciences (Applied Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Applied Biosciences Corp (OTCPK:APPB) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

320 Park Avenue, 18th Floor, New York, NY, USA, 10022

Website

https://www.appliedbiocorp.com

Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.

Executives

Michael Beaubaire	director	9701 WILSHIRE BLVD. SUITE 1000 BEVERLY HILLS CA 90212
John Robert Brady	10 percent owner	9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Raymond W. Urbanski	director, officer: Chief Executive Officer	28903 NORTH AVENUE PAINE, VALENCIA CA 91355
Scott B Stevens	director	9701 WILSHIRE BLVD., SUITE 1000, BEVERLY HILLS CA 90212
Chris Bridges	director, officer: President	9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
John James Southard	officer: Secretary and Treasurer	9701 WILSHIRE BLVD., SUITE 1000 BEVERLY HILLS CA 90212
Sbs Family Trust	10 percent owner	521 RXR PLAZA EAST TOWER ? SUITE 521 UNIONDALE NY 11556